3,232
Views
140
CrossRef citations to date
0
Altmetric
Research Paper

Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells

, , , , , , , , , & show all
Pages 924-938 | Received 20 Jul 2011, Accepted 16 Aug 2011, Published online: 15 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (20)

Aria Dianati-Nasab, Hamid Nasrollahi, Zahra Khoshdel, Mahboobeh Ghorbani & Sayed Mohammad Shafiee. (2022) Overexpression of TIGAR and HO-1 in peripheral blood mononuclear cells (PBMCs) of breast cancer patients treated with radiotherapy. International Journal of Radiation Biology 98:10, pages 1551-1558.
Read now
Rosamaria Lappano, Damiano Cosimo Rigiracciolo, Antonino Belfiore, Marcello Maggiolini & Ernestina Marianna De Francesco. (2020) Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets. Expert Opinion on Therapeutic Targets 24:6, pages 559-572.
Read now
Ji Geng, Xiao Yuan, Mingzhen Wei, Junchao Wu & Zheng-Hong Qin. (2018) The diverse role of TIGAR in cellular homeostasis and cancer. Free Radical Research 52:11-12, pages 1240-1249.
Read now
Suruchi Mittal, Nicola J. Brown & Ingunn Holen. (2018) The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Review of Molecular Diagnostics 18:3, pages 227-243.
Read now
Julieta Afonso, Lúcio L. Santos, António Morais, Teresina Amaro, Adhemar Longatto-Filho & Fátima Baltazar. (2016) Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness. Cell Cycle 15:3, pages 368-380.
Read now
Michael P. Lisanti, Ubaldo E. Martinez-Outschoorn & Federica Sotgia. (2013) Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery. Cell Cycle 12:17, pages 2723-2732.
Read now
Ubaldo E Martinez-Outschoorn, Joseph M Curry, Ying-Hui Ko, Zhao Lin, Madalina Tuluc, David Cognetti, Ruth C Birbe, Edmund Pribitkin, Alessandro Bombonati, Richard G Pestell, Anthony Howell, Federica Sotgia & Michael P Lisanti. (2013) Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment. Cell Cycle 12:16, pages 2580-2597.
Read now
Heath D. Skinner, Matthew R. McCurdy, Alfredo E. Echeverria, Steven H. Lin, James W. Welsh, Michael S. O'Reilly, Wayne L. Hofstetter, Jaffer A. Ajani, Ritsuko Komaki, James D. Cox, Vlad C. Sandulache, Jeffrey N. Myers & Thomas M. Guerrero. (2013) Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncologica 52:5, pages 1002-1009.
Read now
Paola Avena, Wanda Anselmo, Chenguang Wang, Richard G. Pestell, Rebecca S. Lamb, Ivan Casaburi, Sebastiano Andò, Ubaldo E. Martinez-Outschoorn & Michael P. Lisanti. (2013) Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis. Cell Cycle 12:9, pages 1360-1370.
Read now
Joseph M. Curry, Madalina Tuluc, Diana Whitaker-Menezes, Julie A. Ames, Archana Anantharaman, Aileen Butera, Benjamin Leiby, David Cognetti, Federica Sotgia, Michael P. Lisanti & Ubaldo E. Martinez-Outschoorn. (2013) Cancer metabolism, stemness and tumor recurrence. Cell Cycle 12:9, pages 1371-1384.
Read now
Ahmed F. Salem, Mazhar Salim Al-Zoubi, Diana Whitaker-Menezes, Ubaldo E. Martinez-Outschoorn, Rebecca Lamb, James Hulit, Anthony Howell, Ricardo Gandara, Marina Sartini, Ferruccio Galbiati, Generoso Bevilacqua, Federica Sotgia & Michael P. Lisanti. (2013) Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment. Cell Cycle 12:5, pages 818-825.
Read now
Rosa Sanchez-Alvarez, Ubaldo E. Martinez-Outschoorn, Zhao Lin, Rebecca Lamb, James Hulit, Anthony Howell, Federica Sotgia, Emanuel Rubin & Michael P. Lisanti. (2013) Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism. Cell Cycle 12:2, pages 289-301.
Read now
Rosa Sanchez-Alvarez, Ubaldo E. Martinez-Outschoorn, Rebecca Lamb, James Hulit, Anthony Howell, Ricardo Gandara, Marina Sartini, Emanuel Rubin, Michael P. Lisanti & Federica Sotgia. (2013) Mitochondrial dysfunction in breast cancer cells prevents tumor growth. Cell Cycle 12:1, pages 172-182.
Read now
Ubaldo E. Martinez-Outschoorn, Renee Balliet, Zhao Lin, Diana Whitaker-Menezes, Ruth C. Birbe, Alessandro Bombonati, Stephanos Pavlides, Rebecca Lamb, Sharon Sneddon, Anthony Howell, Federica Sotgia & Michael P. Lisanti. (2012) BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment. Cell Cycle 11:23, pages 4402-4413.
Read now
Ubaldo E. Martinez-Outschoorn, Renee M. Balliet, Zhao Lin, Diana Whitaker-Menezes, Anthony Howell, Federica Sotgia & Michael P. Lisanti. (2012) Hereditary ovarian cancer and two-compartment tumor metabolism. Cell Cycle 11:22, pages 4152-4166.
Read now
Claudia Capparelli, Barbara Chiavarina, Diana Whitaker-Menezes, Timothy G. Pestell, Richard G. Pestell, James Hulit, Sebastiano Andò, Anthony Howell, Ubaldo E. Martinez-Outschoorn, Federica Sotgia & Michael P. Lisanti. (2012) CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle 11:19, pages 3599-3610.
Read now
Agnieszka K. Witkiewicz, Diana Whitaker-Menezes, Abhijit Dasgupta, Nancy J. Philp, Zhao Lin, Ricardo Gandara, Sharon Sneddon, Ubaldo E. Martinez-Outschoorn, Federica Sotgia & Michael P. Lisanti. (2012) Using the “reverse Warburg effect” to identify high-risk breast cancer patients. Cell Cycle 11:6, pages 1108-1117.
Read now
Adam Ertel, Aristotelis Tsirigos, Diana Whitaker-Menezes, Ruth Birbe, Stephanos Pavlides, Ubaldo E. Martinez-Outschoorn, Richard G. Pestell, Anthony Howell, Federica Sotgia & Michael P. Lisanti. (2012) Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle 11:2, pages 253-263.
Read now
Ubaldo E. Martinez-Outschoorn, Richard G. Pestell, Anthony Howell, Mark L. Tykocinski, Fnu Nagajyothi, Fabiana S. Machado, Herbert B. Tanowitz, Federica Sotgia & Michael P. Lisanti. (2011) Energy transfer in "parasitic" cancer metabolism. Cell Cycle 10:24, pages 4208-4216.
Read now
Diana Whitaker-Menezes, Ubaldo E. Martinez-Outschoorn, Neal Flomenberg, Ruth Birbe, Agnieszka K. Witkiewicz, Anthony Howell, Stephanos Pavlides, Aristotelis Tsirigos, Adam Ertel, Richard G. Pestell, Paolo Broda, Carlo Minetti, Michael P. Lisanti & Federica Sotgia. (2011) Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ. Cell Cycle 10:23, pages 4047-4064.
Read now

Articles from other publishers (120)

Vincenza Frisardi, Simone Canovi, Salvatore Vaccaro & Raffaele Frazzi. (2023) The Significance of Microenvironmental and Circulating Lactate in Breast Cancer. International Journal of Molecular Sciences 24:20, pages 15369.
Crossref
Yan Chen, Xiaozhen Zhang, Hanshen Yang, Tingbo Liang & Xueli Bai. (2023) The “Self-eating” of cancer-associated fibroblast: A potential target for cancer. Biomedicine & Pharmacotherapy 163, pages 114762.
Crossref
Chen Yi, Jun Yang, Ting Zhang, Shien Xie, Wentao Li, Liu Qin & Dongjuan Chen. (2023) A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment. Clinical and Translational Oncology 25:8, pages 2569-2586.
Crossref
Cynthia Ramírez-Farías, Daniel González-Blas & Andrés Quintanar-Stephano. (2023) El papel del microambiente tumoral y los fibroblastos asociados a cáncer en el desarrollo y la progresión del cáncer de mama. Revista de Senología y Patología Mamaria 36:2, pages 100371.
Crossref
Wei‐Sheng Juan, Yi‐Fen Mu, Chia‐Yih Wang, Edmund‐Cheung So, Yi‐Ping Lee, Sheng‐Che Lin & Bu‐Miin Huang. (2022) Arsenic compounds activate MAPK and inhibit Akt pathways to induce apoptosis in MA ‐10 mouse Leydig tumor cells . Cancer Medicine 12:3, pages 3260-3275.
Crossref
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, Olajumoke Ogunlusi, Mohanad El-Sobky, Biplab Giri & Tapasree Roy Sarkar. (2023) Cancer-associated fibroblasts: The chief architect in the tumor microenvironment. Frontiers in Cell and Developmental Biology 11.
Crossref
Phei Er Saw & Erwei Song. 2023. Tumor Ecosystem. Tumor Ecosystem 371 387 .
Anna Skoczynska & Marta Skoczynska. (2022) Breast Cancer and Arsenic Anticancer Effects: Systematic Review of the Experimental Data from In Vitro Studies. BioMed Research International 2022, pages 1-16.
Crossref
Serena Martinelli, Francesca Amore, Tommaso Mello, Massimo Mannelli, Mario Maggi & Elena Rapizzi. (2022) Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts. Cancers 14:14, pages 3471.
Crossref
Bing Feng, Jianzhong Wu, Bo Shen, Feng Jiang & Jifeng Feng. (2022) Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures. Cancer Cell International 22:1.
Crossref
Roberto Corchado-Cobos, Natalia García-Sancha, Marina Mendiburu-Eliçabe, Aurora Gómez-Vecino, Alejandro Jiménez-Navas, Manuel Jesús Pérez-Baena, Marina Holgado-Madruga, Jian-Hua Mao, Javier Cañueto, Sonia Castillo-Lluva & Jesús Pérez-Losada. (2022) Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer. Cancers 14:2, pages 322.
Crossref
Ella F. Jones, Deep K. Hathi & Nola M. Hylton. 2021. Quantitative Imaging in Medicine. Quantitative Imaging in Medicine 6-1 6-24 .
Eiman Elwakeel & Andreas Weigert. (2021) Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues. International Journal of Molecular Sciences 22:21, pages 11636.
Crossref
Alok Mishra, Anshuman Srivastava, Ankit Pateriya, Manendra Singh Tomar, Anand Kumar Mishra & Ashutosh Shrivastava. (2021) Metabolic reprograming confers tamoxifen resistance in breast cancer. Chemico-Biological Interactions 347, pages 109602.
Crossref
Jenna A. Mosier, Samantha C. Schwager, David A. Boyajian & Cynthia A. Reinhart-King. (2021) Cancer cell metabolic plasticity in migration and metastasis. Clinical & Experimental Metastasis 38:4, pages 343-359.
Crossref
Wei Liang, Xinying He, Jianqiang Bi, Tingting Hu & Yunchuan Sun. (2021) Role of reactive oxygen species in tumors based on the ‘seed and soil’ theory: A complex interaction (Review). Oncology Reports 46:3.
Crossref
Patricia Fernández-Nogueira, Gemma Fuster, Álvaro Gutierrez-Uzquiza, Pere Gascón, Neus Carbó & Paloma Bragado. (2021) Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis. Cancers 13:13, pages 3146.
Crossref
Carina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, Lars Andreas Akslen, Per Malmström, Mårten Fernö, Erik Holmberg, Arne Östman & Per Karlsson. (2021) Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial. Breast Cancer Research and Treatment 187:1, pages 45-55.
Crossref
Dylan Dieters-Castator, Paola M. Dantonio, Matt Piaseczny, Guihua Zhang, Jiahui Liu, Miljan Kuljanin, Stephen Sherman, Michael Jewer, Katherine Quesnel, Eun Young Kang, Martin Köbel, Gabrielle M. Siegers, Andrew Leask, David Hess, Gilles Lajoie & Lynne-Marie Postovit. (2021) Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes. Neoplasia 23:4, pages 375-390.
Crossref
Vida Karimnia, Imran Rizvi, Frank J. Slack & Jonathan P. Celli. (2020) Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models. Photochemistry and Photobiology 97:2, pages 416-426.
Crossref
Fabrizio Marcucci & Cristiano Rumio. (2021) Glycolysis-induced drug resistance in tumors—A response to danger signals?. Neoplasia 23:2, pages 234-245.
Crossref
Umar Mehraj, Abid Hamid Dar, Nissar A. Wani & Manzoor A. Mir. (2021) Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemotherapy and Pharmacology 87:2, pages 147-158.
Crossref
Deepshikha Mishra & Debabrata Banerjee. 2021. Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions. Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions 101 121 .
Bikash Chandra Jena, Chandan Kanta Das, Deblina Bharadwaj & Mahitosh Mandal. (2020) Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:2, pages 188416.
Crossref
Can Ali Agca, Mahinur Kırıcı, Victor S. Nedzvetsky, Ramazan Gundogdu & Artem A. Tykhomyrov. (2020) The Effect of TIGAR Knockdown on Apoptotic and Epithelial‐Mesenchymal Markers Expression in Doxorubicin‐Resistant Non‐Small Cell Lung Cancer A549 Cell Lines. Chemistry & Biodiversity.
Crossref
Marco Fiocchetti, Virginia Solar Fernandez, Marco Segatto, Stefano Leone, Paolo Cercola, Annalisa Massari, Francesco Cavaliere & Maria Marino. (2020) Extracellular Neuroglobin as a Stress-Induced Factor Activating Pre-Adaptation Mechanisms against Oxidative Stress and Chemotherapy-Induced Cell Death in Breast Cancer. Cancers 12:9, pages 2451.
Crossref
Ella F. Jones, Deep K. Hathi, Rita Freimanis, Rita A. Mukhtar, A. Jo Chien, Laura J. Esserman, Laura J. van’t Veer, Bonnie N. Joe & Nola M. Hylton. (2020) Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy. Cancers 12:6, pages 1511.
Crossref
Francesco Di Maggio & Karim Hussien El-Shakankery. (2020) Desmoplasia and Biophysics in Pancreatic Ductal Adenocarcinoma. Pancreas 49:3, pages 313-325.
Crossref
Rui Kang, Herbert Zeh, Michael Lotze & Daolin Tang. 2020. Tumor Microenvironment. Tumor Microenvironment 99 114 .
Jennifer Eng, Guillaume Thibault, Shiuh-Wen Luoh, Joe W. Gray, Young Hwan Chang & Koei Chin. 2020. Biomarkers for Immunotherapy of Cancer. Biomarkers for Immunotherapy of Cancer 521 562 .
Ana S. Dias, Catarina R. Almeida, Luisa A. Helguero & Iola F. Duarte. (2019) Metabolic crosstalk in the breast cancer microenvironment. European Journal of Cancer 121, pages 154-171.
Crossref
Dhruba Kadel, Yu Zhang, Hao-Ran Sun, Yue Zhao, Qiong-Zhu Dong & Lun-xiu Qin. (2019) Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy. Cell Biology and Toxicology 35:5, pages 407-421.
Crossref
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho & Yen-Hua Huang. (2019) Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness. Cancers 11:9, pages 1334.
Crossref
María Inés Diaz Bessone, María José Gattas, Tomás Laporte, Max Tanaka & Marina Simian. (2019) The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer. Frontiers in Endocrinology 10.
Crossref
Xin Xin & Shang-Tian Yang. (2019) A Dual Fluorescent 3-D Multicellular Coculture of Breast Cancer MCF-7 and Fibroblast NIH-3T3 Cells for High Throughput Cancer Drug Screening. Biochemical Engineering Journal 148, pages 152-161.
Crossref
Maria Peiris‐Pagès, Béla Ozsvári, Federica Sotgia & Michael P. Lisanti. (2019) Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer: Mito‐stemness and ribo‐stemness features. Aging 11:14, pages 4801-4835.
Crossref
Cheng Li, Marco K.H. Cheung, Shuo Han, Zhao Zhang, Ling Chen, Junhui Chen, Hui Zeng & Jianxiang Qiu. (2019) Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. Bioscience Reports 39:5.
Crossref
Xin Xin, Hopen Yang, Fengli Zhang & Shang-Tian Yang. (2019) 3D cell coculture tumor model: A promising approach for future cancer drug discovery. Process Biochemistry 78, pages 148-160.
Crossref
Eylem Kulkoyluoglu-Cotul, Alexandra Arca & Zeynep Madak-Erdogan. (2019) Crosstalk between Estrogen Signaling and Breast Cancer Metabolism. Trends in Endocrinology & Metabolism 30:1, pages 25-38.
Crossref
Domenico Ribatti. 2019. Tumor Angiogenesis. Tumor Angiogenesis 313 323 .
Marco Fiorillo, Rosa Sanchez-Alvarez, Federica Sotgia & Michael P. Lisanti. (2018) The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy. Aging 10:12, pages 4000-4023.
Crossref
Konstantina Kyriakopoulou, Elena Kefali, Zoi Piperigkou, Heba Bassiony & Nikos K. Karamanos. (2018) Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer. Cellular Signalling 51, pages 99-109.
Crossref
Yeqi Sun, Ruifen Wang, Meng Qiao, Yanchun Xu, Wenbin Guan & Lifeng Wang. (2018) Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers. Journal of Cellular Physiology 233:9, pages 6359-6369.
Crossref
Angelica Avagliano, Giuseppina Granato, Maria Rosaria Ruocco, Veronica Romano, Immacolata Belviso, Antonia Carfora, Stefania Montagnani & Alessandro Arcucci. (2018) Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts. BioMed Research International 2018, pages 1-12.
Crossref
Jorge A. Belgodere, Connor T. King, Jacob B. Bursavich, Matthew E. Burow, Elizabeth C. Martin & Jangwook P. Jung. (2018) Engineering Breast Cancer Microenvironments and 3D Bioprinting. Frontiers in Bioengineering and Biotechnology 6.
Crossref
Samantha S. Dykes, Veronica S. Hughes, Jennifer M. Wiggins, Henrietta O. Fasanya, Mai Tanaka & Dietmar Siemann. (2018) Stromal cells in breast cancer as a potential therapeutic target. Oncotarget 9:34, pages 23761-23779.
Crossref
Angela Dittmer & Jürgen Dittmer. (2018) Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1. Oncotarget 9:31, pages 22079-22094.
Crossref
Ye.O. Holovenko & I.I. Korshykov. (2018) Species diversity and distribution of lichens in Kryvyi Rih quarry dump complexes. Ukrainian Botanical Journal 75:1, pages 50-58.
Crossref
Kenneth J. Dornfeld & Andrew J. Skildum. 2018. Mitochondrial Biology and Experimental Therapeutics. Mitochondrial Biology and Experimental Therapeutics 153 191 .
Bela Ozsvari, Gloria Bonuccelli, Rosa Sanchez-Alvarez, Richard Foster, Federica Sotgia & Michael P. Lisanti. (2017) Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy. Aging 9:12, pages 2610-2628.
Crossref
Gerald Davies, Liubov Lobanova, Wojciech Dawicki, Gary Groot, John R. Gordon, Matthew Bowen, Troy Harkness & Terra Arnason. (2017) Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer. PLOS ONE 12:12, pages e0187191.
Crossref
Marta Prieto-Vila, Ryou-u Takahashi, Wataru Usuba, Isaku Kohama & Takahiro Ochiya. (2017) Drug Resistance Driven by Cancer Stem Cells and Their Niche. International Journal of Molecular Sciences 18:12, pages 2574.
Crossref
Anne Miller, Csörsz Nagy, Bernhard Knapp, Johannes Laengle, Elisabeth Ponweiser, Marion Groeger, Philipp Starkl, Michael Bergmann, Oswald Wagner & Arvand Haschemi. (2017) Exploring Metabolic Configurations of Single Cells within Complex Tissue Microenvironments. Cell Metabolism 26:5, pages 788-800.e6.
Crossref
Pasquale Sansone, Claudia SaviniIvana KurelacQing ChangLaura Benedetta AmatoAntonio StrillacciAnna StepanovaLuisa IommariniChiara MastroleoLaura DalyAlexander GalkinBasant Kumar ThakurNadine Soplop, Kunihiro Uryu, Ayuko HoshinoLarry NortonMassimiliano BonaféMonica CriccaGiuseppe GasparreDavid LydenJacqueline Bromberg. (2017) Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proceedings of the National Academy of Sciences 114:43.
Crossref
Lukasz Turczyk, Kamila Kitowska, Magdalena Mieszkowska, Kamil Mieczkowski, Dominika Czaplinska, Dominika Piasecka, Radzisław Kordek, Andrzej C. Skladanowski, Piotr Potemski, Hanna M. Romanska & Rafal Sadej. (2017) FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells. Neoplasia 19:10, pages 791-804.
Crossref
Federica Sotgia, Marco Fiorillo & Michael P. Lisanti. (2017) Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics. Oncotarget 8:40, pages 68730-68745.
Crossref
Ernestina Marianna De Francesco, Gloria Bonuccelli, Marcello Maggiolini, Federica Sotgia & Michael P. Lisanti. (2017) Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). Oncotarget 8:40, pages 67269-67286.
Crossref
Junjie Liu, Menghuan Li, Zhong Luo, Liangliang Dai, Xingming Guo & Kaiyong Cai. (2017) Design of nanocarriers based on complex biological barriers in vivo for tumor therapy. Nano Today 15, pages 56-90.
Crossref
Doudou Huang, Fang Yang, Yucai Wang & Xiaoxiang Guan. (2017) Mechanisms of resistance to selective estrogen receptor down-regulator in metastatic breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 148-156.
Crossref
Hoe Suk Kim, Lianji Tian, Hyeonjin Kim & Woo Kyung Moon. (2017) Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using 1H-nuclear magnetic resonance spectroscopy. PLOS ONE 12:6, pages e0179773.
Crossref
T Yu, G Yang, Y Hou, X Tang, C Wu, X-a Wu, L Guo, Q Zhu, H Luo, Y-e Du, S Wen, L Xu, J Yin, G Tu & M Liu. (2016) Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance. Oncogene 36:15, pages 2131-2145.
Crossref
Marco Fiorillo, Federica Sotgia, Diego Sisci, Anna Rita Cappello & Michael P. Lisanti. (2017) Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer. Oncotarget 8:12, pages 20309-20327.
Crossref
Qinglin Zhang, Zhi Liang, Yongxiang Gao, Maikun Teng & Liwen Niu. (2017) Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapies. Gene 596, pages 45-52.
Crossref
Domenico Ribatti. 2017. Tumor Angiogenesis. Tumor Angiogenesis 1 11 .
Janna Paulsson, Lisa Rydén, Carina Strell, Oliver Frings, Nicholas P Tobin, Tommy Fornander, Jonas Bergh, Göran Landberg, Olle Stål & Arne Östman. (2017) High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer. The Journal of Pathology: Clinical Research 3:1, pages 38-43.
Crossref
Qiaosheng Zhang, Jie Li, Haozhe Xie, Hanqing Xue & Yadong Wang. (2016) A network-based pathway-expanding approach for pathway analysis. BMC Bioinformatics 17:S17.
Crossref
Ying-Hui Ko, Marina Domingo-Vidal, Megan Roche, Zhao Lin, Diana Whitaker-Menezes, Erin Seifert, Claudia Capparelli, Madalina Tuluc, Ruth C. Birbe, Patrick Tassone, Joseph M. Curry, Àurea Navarro-Sabaté, Anna Manzano, Ramon Bartrons, Jaime Caro & Ubaldo Martinez-Outschoorn. (2016) TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer. Journal of Biological Chemistry 291:51, pages 26291-26303.
Crossref
Andrea Morandi, Elisa Giannoni & Paola Chiarugi. (2016) Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk. Trends in Cancer 2:12, pages 736-746.
Crossref
Kobra velaei, Nasser Samadi, Balal Barazvan & Jafar Soleimani Rad. (2016) Tumor microenvironment-mediated chemoresistance in breast cancer. The Breast 30, pages 92-100.
Crossref
Brandie N. Radde, Negin Alizadeh-Rad, Stephanie M. Price, David J. Schultz & Carolyn M. Klinge. (2016) Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells. Journal of Cellular Biochemistry 117:11, pages 2521-2532.
Crossref
Joseph M. CurryPatrick TassonePaolo CotziaJohn SprandioAdam LuginbuhlDavid M. CognettiMehri MollaeeMarina Domingo-VidalEdmund A. PribitkinWilliam M. KeaneTingting ZhanRuth BirbeMadalina TulucUbaldo Martinez-Outschoorn. (2016) Multicompartment metabolism in papillary thyroid cancer. The Laryngoscope 126:10, pages 2410-2418.
Crossref
Kristin Stock, Marta F. Estrada, Suzana Vidic, Kjersti Gjerde, Albin Rudisch, Vítor E. Santo, Michaël Barbier, Sami Blom, Sharath C. Arundkar, Irwin Selvam, Annika Osswald, Yan Stein, Sylvia Gruenewald, Catarina Brito, Wytske van Weerden, Varda Rotter, Erwin Boghaert, Moshe Oren, Wolfgang Sommergruber, Yolanda Chong, Ronald de Hoogt & Ralph Graeser. (2016) Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Scientific Reports 6:1.
Crossref
Kaifu Li, Hua Kang, Yajun Wang, Tao Hai, Guohua Rong & Haichen Sun. (2016) Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology. Medical Oncology 33:7.
Crossref
Guo-Ying Miao, Xin Zhou, Xin Zhang, Yi Xie, Chao Sun, Yang Liu, Lu Gan & Hong Zhang. (2016) Telomere-Mitochondrion Links Contribute to Induction of Senescence in MCF-7 Cells after Carbon-Ion Irradiation. Asian Pacific Journal of Cancer Prevention 17:4, pages 1993-1998.
Crossref
Genichiro Ishii, Atsushi Ochiai & Shinya Neri. (2016) Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Advanced Drug Delivery Reviews 99, pages 186-196.
Crossref
Poliana Camila Marinello, Thamara Nishida Xavier da Silva, Carolina Panis, Amanda Fouto Neves, Kaliana Larissa Machado, Fernando Henrique Borges, Flávia Alessandra Guarnier, Sara Santos Bernardes, Júlio Cesar Madureira de-Freitas-Junior, José Andrés Morgado-Díaz, Rodrigo Cabral Luiz, Rubens Cecchini & Alessandra Lourenço Cecchini. (2015) Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction. Tumor Biology 37:4, pages 5337-5346.
Crossref
Rachel Buchsbaum & Sun Oh. (2016) Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go. Cancers 8:2, pages 19.
Crossref
William Walter, Jennifer Thomalla, Josh Bruhn, Dedra H. Fagan, Cheryl Zehowski, Douglas Yee & Andrew Skildum. (2015) Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells. SpringerPlus 4:1.
Crossref
Benjamin Leyh, Angela Dittmer, Theresia Lange, John W. M. Martens & Jürgen Dittmer. (2015) Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis. Oncotarget 6:36, pages 39307-39328.
Crossref
George Notas, Vassiliki Pelekanou, Marilena Kampa, Konstantinos Alexakis, Stelios Sfakianakis, Aggelos Laliotis, John Askoxilakis, Eleftheria Tsentelierou, Maria Tzardi, Andreas Tsapis & Elias Castanas. (2015) Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors. Molecular Oncology 9:9, pages 1744-1759.
Crossref
Gillian Farnie, Federica Sotgia & Michael P. Lisanti. (2015) High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Oncotarget 6:31, pages 30472-30486.
Crossref
Tien-Ling Liao, Chii-Ruey Tzeng, Chao-Lan Yu, Yi-Pei Wang & Shu-Huei Kao. (2015) Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis. Annals of the New York Academy of Sciences 1350:1, pages 52-60.
Crossref
Prathap Kumar S. Mahalingaiah, Logeswari Ponnusamy & Kamaleshwar P. Singh. (2015) Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells. Breast Cancer Research and Treatment 153:1, pages 41-56.
Crossref
Arianna De Luca, Marco Fiorillo, Maria Peiris-Pagès, Bela Ozsvari, Duncan L. Smith, Rosa Sanchez-Alvarez, Ubaldo E. Martinez-Outschoorn, Anna Rita Cappello, Vincenzo Pezzi, Michael P. Lisanti & Federica Sotgia. (2015) Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells. Oncotarget 6:17, pages 14777-14795.
Crossref
Haojun Luo, Gang Tu, Zhimin Liu & Manran Liu. (2015) Cancer-associated fibroblasts: A multifaceted driver of breast cancer progression. Cancer Letters 361:2, pages 155-163.
Crossref
Cynthia X. Ma, Tomás Reinert, Izabela Chmielewska & Matthew J. Ellis. (2015) Mechanisms of aromatase inhibitor resistance. Nature Reviews Cancer 15:5, pages 261-275.
Crossref
Florian Klemm & Johanna A. Joyce. (2015) Microenvironmental regulation of therapeutic response in cancer. Trends in Cell Biology 25:4, pages 198-213.
Crossref
Jürgen Dittmer & Benjamin Leyh. (2015) The impact of tumor stroma on drug response in breast cancer. Seminars in Cancer Biology 31, pages 3-15.
Crossref
Andrés Caicedo, Vanessa Fritz, Jean-Marc Brondello, Mickaël Ayala, Indira Dennemont, Naoill Abdellaoui, Florence de Fraipont, Anaïck Moisan, Claire Angebault Prouteau, Hassan Boukhaddaoui, Christian Jorgensen & Marie-Luce Vignais. (2015) MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function. Scientific Reports 5:1.
Crossref
ELAINE YUE LING WONG, SZE-CHUEN CESAR WONG, CHARLES MING LOK CHAN, EMILY KAI YEE LAM, LOUISA YEUNG HO, CECILIA PIK YUK LAU, THOMAS CHI CHUEN AU, AMANDA KIT CHING CHAN, CHI MAN TSANG, SAI WAH TSAO, VIVIAN WAI YAN LUI & ANTHONY TAK CHEUNG CHAN. (2015) TP53-induced glycolysis and apoptosis regulator promotes proliferation and invasiveness of nasopharyngeal carcinoma cells. Oncology Letters 9:2, pages 569-574.
Crossref
Wen Tan, Zhangfeng Zhong, Shengpeng Wang, Zhanwei Suo, Xian Yang, Xiaodong Hu & Yitao Wang. (2015) Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-10.
Crossref
Ning Yang, Tao Yan, Huaiyang Zhu, Xiao Liang, Lina Leiss, Per Øystein Sakariassen, Kai Ove Skaftnesmo, Bin Huang, Daniela Elena Costea, Per Øyvind Enger, Xingang Li & Jian Wang. (2014) A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma. Journal of Translational Medicine 12:1.
Crossref
Kamolporn Amornsupak, Tonkla Insawang, Peti Thuwajit, Pornchai O-Charoenrat, Suzanne A Eccles & Chanitra Thuwajit. (2014) Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells. BMC Cancer 14:1.
Crossref
Mauricio P Pinto, Wendy W Dye, Britta M Jacobsen & Kathryn B Horwitz. (2014) Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling. BMC Cancer 14:1.
Crossref
Carmen Criscitiello, Angela Esposito & Giuseppe Curigliano. (2014) Tumor–stroma crosstalk. Current Opinion in Oncology 26:6, pages 551-555.
Crossref
Fabrizio Marcucci, Matteo Bellone, Carmelo Antonio Caserta & Angelo Corti. (2014) Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads. International Journal of Cancer 135:6, pages 1265-1276.
Crossref
OU HUANG, ZUOQUAN XIE, WEILI ZHANG, YING LOU, YAN MAO, HONGCHUN LIU, MIN JIANG & KUNWEI SHEN. (2014) A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cells. Oncology Reports 32:2, pages 627-634.
Crossref
Stefania Catalano, Cinzia Giordano, Salvatore Panza, Francesca Chemi, Daniela Bonofiglio, Marilena Lanzino, Pietro Rizza, Francesco Romeo, Suzanne A. W. Fuqua, Marcello Maggiolini, Sebastiano And?Ines Barone. (2014) Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth. Breast Cancer Research and Treatment 146:2, pages 273-285.
Crossref
Ensieh Farahani, Hirak K. Patra, Jaganmohan R. Jangamreddy, Iran Rashedi, Marta Kawalec, Rama K. Rao Pariti, Petros Batakis & Emilia Wiechec. (2014) Cell adhesion molecules and their relation to (cancer) cell stemness. Carcinogenesis 35:4, pages 747-759.
Crossref
Ubaldo Martinez-Outschoorn, Federica Sotgia & Michael P. Lisanti. (2014) Tumor Microenvironment and Metabolic Synergy in Breast Cancers: Critical Importance of Mitochondrial Fuels and Function. Seminars in Oncology 41:2, pages 195-216.
Crossref
Janna Paulsson & Patrick Micke. (2014) Prognostic relevance of cancer-associated fibroblasts in human cancer. Seminars in Cancer Biology 25, pages 61-68.
Crossref
Ubaldo E. Martinez-Outschoorn, Michael P. Lisanti & Federica Sotgia. (2014) Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Seminars in Cancer Biology 25, pages 47-60.
Crossref
Denise Buenrostro, Serk In Park & Julie A. Sterling. (2014) Dissecting the Role of Bone Marrow Stromal Cells on Bone Metastases. BioMed Research International 2014, pages 1-11.
Crossref
Margarita Aguilera & Juan Antonio Marchal. 2014. Omics Approaches in Breast Cancer. Omics Approaches in Breast Cancer 277 295 .
Brigid C. Browne, Falko Hochgräfe, Jianmin Wu, Ewan K. A. Millar, Jane Barraclough, Andrew Stone, Rachael A. McCloy, Christine S. Lee, Caroline Roberts, Naveid A. Ali, Alice Boulghourjian, Fabian Schmich, Rune Linding, Lynn Farrow, Julia M. W. Gee, Robert I. Nicholson, Sandra A. O'Toole, Robert L. Sutherland, Elizabeth A. Musgrove, Alison J. Butt & Roger J. Daly. (2013) Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. FEBS Journal 280:21, pages 5237-5257.
Crossref
Suzanne A Eccles, Eric O Aboagye, Simak Ali, Annie S Anderson, Jo Armes, Fedor Berditchevski, Jeremy P Blaydes, Keith Brennan, Nicola J Brown, Helen E Bryant, Nigel J Bundred, Joy M Burchell, Anna M Campbell, Jason S Carroll, Robert B Clarke, Charlotte E Coles, Gary JR Cook, Angela Cox, Nicola J Curtin, Lodewijk V Dekker, Isabel dos Santos Silva, Stephen W Duffy, Douglas F Easton, Diana M Eccles, Dylan R Edwards, Joanne Edwards, D Gareth Evans, Deborah F Fenlon, James M Flanagan, Claire Foster, William M Gallagher, Montserrat Garcia-Closas, Julia M W Gee, Andy J Gescher, Vicky Goh, Ashley M Groves, Amanda J Harvey, Michelle Harvie, Bryan T Hennessy, Stephen Hiscox, Ingunn Holen, Sacha J Howell, Anthony Howell, Gill Hubbard, Nick Hulbert-Williams, Myra S Hunter, Bharat Jasani, Louise J Jones, Timothy J Key, Cliona C Kirwan, Anthony Kong, Ian H Kunkler, Simon P Langdon, Martin O Leach, David J Mann, John F Marshall, Lesley Ann Martin, Stewart G Martin, Jennifer E Macdougall, David W Miles, William R Miller, Joanna R Morris, Sue M Moss, Paul Mullan, Rachel Natrajan, James PB O’Connor, Rosemary O’Connor, Carlo Palmieri, Paul D P Pharoah, Emad A Rakha, Elizabeth Reed, Simon P Robinson, Erik Sahai, John M Saxton, Peter Schmid, Matthew J Smalley, Valerie Speirs, Robert Stein, John Stingl, Charles H Streuli, Andrew N J Tutt, Galina Velikova, Rosemary A Walker, Christine J Watson, Kaye J Williams, Leonie S Young & Alastair M Thompson. (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Research 15:5.
Crossref
Federica Sotgia, Ubaldo E. Martinez-Outschoorn & Michael P. Lisanti. (2013) Cancer Metabolism: New Validated Targets for Drug Discovery. Oncotarget 4:8, pages 1309-1316.
Crossref
Ubaldo E. Martinez-Outschoorn, Diana Whitaker-Menezes, Matias Valsecchi, Maria P. Martinez-Cantarin, Alina Dulau-Florea, Jerald Gong, Anthony Howell, Neal Flomenberg, Richard G. Pestell, John Wagner, Cecilia Arana-Yi, Manish Sharma, Federica Sotgia & Michael P. Lisanti. (2013) Reverse Warburg Effect in a Patient With Aggressive B-Cell Lymphoma: Is Lactic Acidosis a Paraneoplastic Syndrome?. Seminars in Oncology 40:4, pages 403-418.
Crossref
Rosalind Brigham Penney & Deodutta Roy. (2013) Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:1, pages 60-79.
Crossref
Yan Mao, Evan T. Keller, David H. Garfield, Kunwei Shen & Jianhua Wang. (2012) Stromal cells in tumor microenvironment and breast cancer. Cancer and Metastasis Reviews 32:1-2, pages 303-315.
Crossref
Athena Kritharis, Thomas P. Bradley & Daniel R. Budman. (2013) The evolving use of arsenic in pharmacotherapy of malignant disease. Annals of Hematology 92:6, pages 719-730.
Crossref
Dimitrios Zardavas, José Baselga & Martine Piccart. (2013) Emerging targeted agents in metastatic breast cancer. Nature Reviews Clinical Oncology 10:4, pages 191-210.
Crossref
Félix A. Urra, Maximiliano Martínez-Cifuentes, Mario Pavani, Michel Lapier, Fabián Jaña-Prado, Eduardo Parra, Juan Diego Maya, Hernán Pessoa-Mahana, Jorge Ferreira & Ramiro Araya-Maturana. (2013) An ortho-carbonyl substituted hydroquinone derivative is an anticancer agent that acts by inhibiting mitochondrial bioenergetics and by inducing G2/M-phase arrest in mammary adenocarcinoma TA3. Toxicology and Applied Pharmacology 267:3, pages 218-227.
Crossref
Agnieszka Jezierska-Drutel, Steven A. Rosenzweig & Carola A. Neumann. 2013. 107 125 .
Rajesh R. Nair, Anthony W. Gebhard & Lori A. Hazlehurst. 2013. Cell Death Signaling in Cancer Biology and Treatment. Cell Death Signaling in Cancer Biology and Treatment 53 86 .
Nan Liu, Sheng Tai, Boxiao Ding, Ryan K Thor, Sunita Bhuta, Yin Sun & Jiaoti Huang. (2012) Arsenic trioxide synergizes with everolimus (Rad001) to induce cytotoxicity of ovarian cancer cells through increased autophagy and apoptosis. Endocrine-Related Cancer 19:5, pages 711-723.
Crossref
Jason R. Cantor & David M. Sabatini. (2012) Cancer Cell Metabolism: One Hallmark, Many Faces. Cancer Discovery 2:10, pages 881-898.
Crossref
Arne Östman. (2012) The tumor microenvironment controls drug sensitivity. Nature Medicine 18:9, pages 1332-1334.
Crossref
Inês A. Barbosa, Nuno G. Machado, Andrew J. Skildum, Patricia M. Scott & Paulo J. Oliveira. (2012) Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1826:1, pages 238-254.
Crossref
Ubaldo E. Martinez-Outschoorn, Federica Sotgia & Michael P. Lisanti. (2012) Power Surge: Supporting Cells “Fuel” Cancer Cell Mitochondria. Cell Metabolism 15:1, pages 4-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.